ZEPHYR AI
Zephyr AI is a high-growth healthcare technology company committed to radically reshaping traditional approaches to drug discovery and precision medicine. Zephyr AI collaborates with top health systems, health insurance plans, and biotechnology innovators to enhance Quality, Outcomes, and Costs.
ZEPHYR AI
Industry:
Artificial Intelligence (AI) Biotechnology Medical
Founded:
2020-01-01
Address:
Fairfax Station, Virginia, United States
Country:
United States
Website Url:
http://www.zephyrai.bio
Total Employee:
11+
Status:
Active
Total Funding:
129.5 M USD
Technology used in webpage:
Domain Not Resolving HSTS ReCAPTCHA ReCAPTCHA V2 Amazon CloudFront Amazon Cognito Cloudflare Radar AWS Cloudfront Taipei TW Edge Cloudflare Radar Top 500k AWS Cloudfront Manila Edge
Similar Organizations
MapLight Therapeutics
MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.
Arctic Therapeutics
Arctic Therapeutics (AT) uses bioinformatic approaches and AI to eliminate major risks associated with traditional drug development.
Coriell Life Sciences
Coriell Life Sciences delivers the power of precision medicine using pharmacogenomics and clinical decision support software.
Ocean Biomedical
Ocean Biomedical is a biotechnology company that accelerates new discoveries in the world of medicine.
OM1
OM1 is a healthcare technology company that leverages real-world clinical data for medical research and personalized medicine.
Proscia
Proscia develops a pathology platform to assist routine pathology operations, enhance cancer diagnosis, and improve patient outcomes.
Vivodyne
Vivodyne develops an automated robotic system that discovers life-changing drugs and cellular therapies.
Current Employees Featured
Founder
Investors List
Eli Lilly & Company Foundation
Eli Lilly & Company Foundation investment in Series A - Zephyr AI
Revolution Growth
Revolution Growth investment in Series A - Zephyr AI
Jeff Skoll
Jeff Skoll investment in Series A - Zephyr AI
EPIQ Capital Group
EPIQ Capital Group investment in Series A - Zephyr AI
Allen Chao
Allen Chao investment in Seed Round - Zephyr AI
BoxGroup
BoxGroup investment in Seed Round - Zephyr AI
Lerner Enterprises
Lerner Enterprises investment in Seed Round - Zephyr AI
Liquid 2 Ventures
Liquid 2 Ventures investment in Seed Round - Zephyr AI
AME Cloud Ventures
AME Cloud Ventures investment in Seed Round - Zephyr AI
MedStar Health
MedStar Health investment in Seed Round - Zephyr AI
Key Employee Changes
Date | New article |
---|---|
2024-04-02 | Rachael Brake, PhD, Joins Zephyr AI as Chief Scientific Officer |
2023-06-05 | Experienced Biotech Executive and Deal Maker Joins Zephyr AI as Chief Business Officer |
Official Site Inspections
http://www.zephyrai.bio Semrush global rank: 6.25 M Semrush visits lastest month: 1.07 K
- Host name: ec2-52-4-138-112.compute-1.amazonaws.com
- IP address: 52.4.138.112
- Location: Ashburn United States
- Latitude: 39.0481
- Longitude: -77.4728
- Metro Code: 511
- Timezone: America/New_York
- Postal: 20149
More informations about "Zephyr AI"
Zephyr AI
At Zephyr we're building a team of highly motivated experts who: Thrive in cross disciplinary environments; Revel in the continuous cycle of learning and teaching, fostering a culture of โฆSee details»
Zephyr's Unique Federated Data Powers Our Models - zephyrai.bio
Zephyr possesses one of the largest clinicogenomic datasets in the world, including over 68 million longitudinal patient records updated at regular intervals. Our foundational AI models โฆSee details»
Zephyr AI - Crunchbase Company Profile & Funding
Zephyr AI is a healthcare technology company that reshapes traditional approaches to drug discovery and precision medicine.See details»
From data ingestion to production in less than 30 days: โฆ
Zephyr AI combines data science with engineering to help health providers and plans transform prevention, care delivery, and treatment. The Zephyr platform ingests real-world data, then uses transparent artificial intelligence (AI) and โฆSee details»
Zephyr AI - LinkedIn
Zephyr AI uses large complex data and proprietary algorithms to discover new insights and opportunities for Personalized/Precision Medicine, Drug Discovery, Drug Rescue, and Clinical Decision Support.See details»
Zephyr AI Raises $18.5 Million in Seed Funding Led by โฆ
Mar 30, 2022 As an organization deeply committed to being at the forefront of successful initiatives in medical research, we are delighted to be participating.โ ... [email protected]. Recent News Team Cincoro Unleashed: All- Star Lineup โฆSee details»
Red Cell Forms Zephyr AI to Revolutionize Drug โฆ
Nov 22, 2021 To stay up-to-date: visit us at www.zephyrai.bio and follow us on LinkedIn. Contacts Media Contact: Charles V. Zehren Rubenstein 212-843-8590 [email protected]See details»
Zephyr AI Raises $111 Million in Series A Financing
MCLEAN, Va., March 13, 2024--Zephyr AI, Inc. ("Zephyr AI"), a healthcare technology company committed to developing fast and explainable Artificial Intelligence (AI) solutions to โฆSee details»
Experienced Biotech Executive and Deal Maker Joins Zephyr AI as โฆ
Jun 5, 2023 Visit us at www.zephyrai.bio and follow us on Twitter, Instagram, and LinkedIn. Contacts Katie Griff Head of Marketing, Zephyr AI [email protected] Liz Boten Evoke Canale โฆSee details»
Zephyr AI
AI-enabled composite biomarkers for enhanced clinical development. Work at Zephyr AI. We are a multidisciplinary team of world-class software engineers, scientists, and entrepreneurs โฆSee details»
Zephyr AI Raises $18.5 Million in Seed Funding Led by Lerner and โฆ
Mar 30, 2022 As an organization deeply committed to being at the forefront of successful initiatives in medical research, we are delighted to be participating.โ ... Visit us at zephyrai.bio โฆSee details»
Zephyr AI - Company info. interviews, news - BiopharmaTrend
Https://www.zephyrai.bio. Founded 2021. Publications 2. Zephyr AI is a high-growth healthcare technology company committed to radically rebuilding drug discovery and precision medicine โฆSee details»
Zephyr AI - Craft
Zephyr AI has 5 employees at their 1 location and $18.5 m in total funding,. See insights on Zephyr AI including office locations, competitors, revenue, financials, executives, subsidiaries โฆSee details»
Zephyr AI Raises $111 Million in Series A Financing
Mar 13, 2024 MCLEAN, Va.--(BUSINESS WIRE)--Zephyr AI, Inc. (โZephyr AIโ), a healthcare technology company committed to developing fast and explainable Artificial Intelligence (AI) โฆSee details»
Zephyr AI taps biotech executive Rachael Blake as CSO - Fierce โฆ
Apr 2, 2024 Three-year-old AI precision medicine company Zephyr AI brought on board a scientist and executive with deep biotech and pharma experience to lead its strategic and โฆSee details»
Zephyr AI Announces the Appointment of John Applegate as its CFO
May 16, 2024 Applegateโs appointment comes as Zephyr AI prepares to present a scientific poster (Abstract # 5583/454: Evaluation of novel signature for PARP inhibitor sensitivity โฆSee details»
Zephyr AI noncon deck September-25-24
The Value Proposition of Patient Selection Is Unambiguous $23.0 $7.1 $6.3 $0.7 $7.0 $4.7 $3.2 $3.5 $3.1 $2.5 $5.3 Potential R&D Cost Savings with CDx by Disease CDx Can Cut Clinical โฆSee details»
Zephyr AI Presents the Development of a Novel AI-Enabled โฆ
MCLEAN, Va., June 03, 2024--Zephyr AI, a high-growth healthcare technology company committed to developing AI-Enabled Composite Biomarkers to expand the horizon of precision โฆSee details»
Zephyr AI
AI-enabled composite biomarkers for enhanced clinical developmentSee details»